Medrio Overview

  • Year Founded
  • 2005

Year Founded

  • Status
  • Private

  • Employees
  • 173

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 11

Medrio General Information

Description

Operator of an efficient e-clinical platform designed to offer clinical studies in all phases and therapeutic areas. The company's platform provides web-based electronic data for clinical research applications and also supports various processes for clinical research, study design, data collection, management reports, statistical analyses, and presentation, enabling study sponsors and contract research organizations (CROs) to rapidly set up and conduct clinical trials.

Contact Information

Website
www.medrio.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 345 California Street
  • Suite 600
  • San Francisco, CA 94104
  • United States
+1 (415)
Primary Industry
Business/Productivity Software
Other Industries
Vertical Market Software
Other Healthcare Technology Systems
Vertical(s)
SaaS, TMT, HealthTech
Corporate Office
  • 345 California Street
  • Suite 600
  • San Francisco, CA 94104
  • United States
+1 (415)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Medrio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Accelerator/Incubator Completed Generating Revenue
6. Later Stage VC Completed Generating Revenue
5. Secondary Transaction - Private 04-Sep-2020 Completed Generating Revenue
4. Debt - PPP 27-Apr-2020 Completed Generating Revenue
3. Later Stage VC 24-May-2017 Completed Generating Revenue
2. Later Stage VC (Series 1) 01-Jun-2013 $1.6M $3.63M Completed Generating Revenue
1. Seed Round 28-Oct-2011 $2.03M $2.03M Completed Generating Revenue
To view Medrio’s complete valuation and funding history, request access »

Medrio Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate ($) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series Growth
Series 1
Seed 4,428,068 $0.000100 $0.09 $1.2 $1.2 1x $1.2 23.64%
To view Medrio’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Medrio Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of an efficient e-clinical platform designed to offer clinical studies in all phases and therapeutic areas. The
Business/Productivity Software
San Francisco, CA
173 As of 2026

Paris, France
 

Atlanta, GA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Medrio Competitors (31)

One of Medrio’s 31 competitors is Ennov, a Private Equity-Backed company based in Paris, France.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Ennov Private Equity-Backed Paris, France
Florence (Business/Productivity Software) Venture Capital-Backed Atlanta, GA
CluePoints Private Equity-Backed Louvain-La-Neuve, Belgium
YPrime Private Equity-Backed Malvern, PA
AMC Health Private Equity-Backed New York, NY
You’re viewing 5 of 31 competitors. Get the full list »

Medrio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Medrio Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
Questa Capital Venture Capital Minority
Think + Venture Capital Minority
Montage Capital Lender/Debt Provider Minority
Angel (individual) Minority
Angel (individual) Minority
You’re viewing 5 of 11 investors. Get the full list »

Medrio Acquisitions (2)

Medrio’s most recent deal was a Merger/Acquisition with HMD Clinical. The deal was made on 15-Apr-2021.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
HMD Clinical 15-Apr-2021 Merger/Acquisition IT Consulting and Outsourcing
DFS Pharma Merger/Acquisition Systems and Information Management
To view Medrio’s complete acquisitions history, request access »

Ready to get started?

Request a free trial

Medrio FAQs

  • When was Medrio founded?

    Medrio was founded in 2005.

  • Where is Medrio headquartered?

    Medrio is headquartered in San Francisco, CA.

  • What is the size of Medrio?

    Medrio has 173 total employees.

  • What industry is Medrio in?

    Medrio’s primary industry is Business/Productivity Software.

  • Is Medrio a private or public company?

    Medrio is a Private company.

  • What is Medrio’s current revenue?

    The current revenue for Medrio is .

  • How much funding has Medrio raised over time?

    Medrio has raised $33.6M.

  • Who are Medrio’s investors?

    Questa Capital, Think +, Montage Capital, , and are 5 of 11 investors who have invested in Medrio.

  • Who are Medrio’s competitors?

    Ennov, Florence (Business/Productivity Software), CluePoints, YPrime, and AMC Health are some of the 31 competitors of Medrio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process